Capsid protein VP1
OrganismNot specified
State in the Current Structure
| Assembly | Oligomeric State | Construct | Mutations and Modifications | Ligands, Ions and Associated Components | Method and Experimental Conditions | Structure Quality |
|---|---|---|---|---|---|---|
| 1 | Protein homooligomer Homooligomer Protein × 240 PDB declaration: 240-meric(240) Consistent with protein copy count | Chain A; UniProt 569–867 Chain B; UniProt 70–330 Chain C; UniProt 331–568 Chain D; UniProt 2–69 | Not recorded | PLM PALMITIC ACID × 60 MYR MYRISTIC ACID × 60 | ELECTRON MICROSCOPY cryo-EM buffer:pH 7.2 cryo-EM vitrification conditions:Cryogen ETHANE;Sample was incubated for 15 s on the grid before blotted from the front for 1.5 s. | Resolution 2.50 Å |
Other States of the Same Protein in the Database
Each row is a biological assembly of the same UniProt protein in another PDB entry. The “Difference from current entry” column identifies evidence-level differences; no tag means the currently parsed fields agree.
| Other PDB | Difference from Current Entry 9FP5 | Assembly / Oligomeric State | Construct | Mutations and Modifications | Ligands, Ions and Non-polymers | Method and Experimental Conditions | Structure Quality |
|---|---|---|---|---|---|---|---|
| 1D4M THE CRYSTAL STRUCTURE OF COXSACKIEVIRUS A9 TO 2.9 A RESOLUTION Deposited 1999-10-04 | Different construct Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 240 PDB declaration: 240-MERIC |
Chain 1
568–866(299 aa)
Fragment:VP1
Chain 2
69–329(261 aa)
Fragment:VP2
Chain 3
330–567(238 aa)
Fragment:VP3
Chain 4
1–68(68 aa)
Fragment:VP4
|
Not recorded | W71 5-(7-(4-(4,5-DIHYDRO-2-OXAZOLYL)PHENOXY)HEPTYL)-3-METHYL ISOXAZOLE × 120 MYR MYRISTIC ACID × 60 | X-RAY DIFFRACTION mmCIF provides none of the parsed conditions | Resolution 2.90 Å |
| 1D4M THE CRYSTAL STRUCTURE OF COXSACKIEVIRUS A9 TO 2.9 A RESOLUTION Deposited 1999-10-04 | Different construct Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 2 Protein homooligomer Homooligomer;Protein × 4 PDB declaration: tetrameric |
Chain 1
568–866(299 aa)
Fragment:VP1
Chain 2
69–329(261 aa)
Fragment:VP2
Chain 3
330–567(238 aa)
Fragment:VP3
Chain 4
1–68(68 aa)
Fragment:VP4
|
Not recorded | W71 5-(7-(4-(4,5-DIHYDRO-2-OXAZOLYL)PHENOXY)HEPTYL)-3-METHYL ISOXAZOLE × 2 MYR MYRISTIC ACID × 1 | X-RAY DIFFRACTION mmCIF provides none of the parsed conditions | Resolution 2.90 Å |
| 1D4M THE CRYSTAL STRUCTURE OF COXSACKIEVIRUS A9 TO 2.9 A RESOLUTION Deposited 1999-10-04 | Different construct Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 3 Protein homooligomer Homooligomer;Protein × 20 PDB declaration: eicosameric |
Chain 1
568–866(299 aa)
Fragment:VP1
Chain 2
69–329(261 aa)
Fragment:VP2
Chain 3
330–567(238 aa)
Fragment:VP3
Chain 4
1–68(68 aa)
Fragment:VP4
|
Not recorded | W71 5-(7-(4-(4,5-DIHYDRO-2-OXAZOLYL)PHENOXY)HEPTYL)-3-METHYL ISOXAZOLE × 10 MYR MYRISTIC ACID × 5 | X-RAY DIFFRACTION mmCIF provides none of the parsed conditions | Resolution 2.90 Å |
| 1D4M THE CRYSTAL STRUCTURE OF COXSACKIEVIRUS A9 TO 2.9 A RESOLUTION Deposited 1999-10-04 | Different construct Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 4 Protein homooligomer Homooligomer;Protein × 24 PDB declaration: 24-meric |
Chain 1
568–866(299 aa)
Fragment:VP1
Chain 2
69–329(261 aa)
Fragment:VP2
Chain 3
330–567(238 aa)
Fragment:VP3
Chain 4
1–68(68 aa)
Fragment:VP4
|
Not recorded | W71 5-(7-(4-(4,5-DIHYDRO-2-OXAZOLYL)PHENOXY)HEPTYL)-3-METHYL ISOXAZOLE × 12 MYR MYRISTIC ACID × 6 | X-RAY DIFFRACTION mmCIF provides none of the parsed conditions | Resolution 2.90 Å |
| 1D4M THE CRYSTAL STRUCTURE OF COXSACKIEVIRUS A9 TO 2.9 A RESOLUTION Deposited 1999-10-04 | Different construct Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 5 Protein homooligomer Homooligomer;Protein × 4 PDB declaration: tetrameric |
Chain 1
568–866(299 aa)
Fragment:VP1
Chain 2
69–329(261 aa)
Fragment:VP2
Chain 3
330–567(238 aa)
Fragment:VP3
Chain 4
1–68(68 aa)
Fragment:VP4
|
Not recorded | W71 5-(7-(4-(4,5-DIHYDRO-2-OXAZOLYL)PHENOXY)HEPTYL)-3-METHYL ISOXAZOLE × 2 MYR MYRISTIC ACID × 1 | X-RAY DIFFRACTION mmCIF provides none of the parsed conditions | Resolution 2.90 Å |
| 1D4M THE CRYSTAL STRUCTURE OF COXSACKIEVIRUS A9 TO 2.9 A RESOLUTION Deposited 1999-10-04 | Different construct Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 6 Protein homooligomer Homooligomer;Protein × 120 PDB declaration: 120-meric |
Chain 1
568–866(299 aa)
Fragment:VP1
Chain 2
69–329(261 aa)
Fragment:VP2
Chain 3
330–567(238 aa)
Fragment:VP3
Chain 4
1–68(68 aa)
Fragment:VP4
|
Not recorded | W71 5-(7-(4-(4,5-DIHYDRO-2-OXAZOLYL)PHENOXY)HEPTYL)-3-METHYL ISOXAZOLE × 60 MYR MYRISTIC ACID × 30 | X-RAY DIFFRACTION mmCIF provides none of the parsed conditions | Resolution 2.90 Å |
| 3J2J Empty coxsackievirus A9 capsid Deposited 2012-10-04 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 180 PDB declaration: 180-meric |
Chain A
631–852(222 aa)
Fragment:UNP residues 631-852
Chain B
331–568(238 aa)
Fragment:UNP residues 331-568
Chain C
79–330(252 aa)
Fragment:UNP residues 79-330
|
Not recorded | No recorded non-water small molecule |
ELECTRON MICROSCOPY
cryo-EM vitrification conditions
manual plunging;Cryogen ETHANE;manual plunging into liquid ethane (GATAN CRYOPLUNGE 3)
|
Resolution 9.54 Å |
| 3J2J Empty coxsackievirus A9 capsid Deposited 2012-10-04 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein homooligomer Homooligomer;Protein × 3 PDB declaration: trimeric |
Chain A
631–852(222 aa)
Fragment:UNP residues 631-852
Chain B
331–568(238 aa)
Fragment:UNP residues 331-568
Chain C
79–330(252 aa)
Fragment:UNP residues 79-330
|
Not recorded | No recorded non-water small molecule |
ELECTRON MICROSCOPY
cryo-EM vitrification conditions
manual plunging;Cryogen ETHANE;manual plunging into liquid ethane (GATAN CRYOPLUNGE 3)
|
Resolution 9.54 Å |
| 3J2J Empty coxsackievirus A9 capsid Deposited 2012-10-04 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 3 Protein homooligomer Homooligomer;Protein × 15 PDB declaration: pentadecameric |
Chain A
631–852(222 aa)
Fragment:UNP residues 631-852
Chain B
331–568(238 aa)
Fragment:UNP residues 331-568
Chain C
79–330(252 aa)
Fragment:UNP residues 79-330
|
Not recorded | No recorded non-water small molecule |
ELECTRON MICROSCOPY
cryo-EM vitrification conditions
manual plunging;Cryogen ETHANE;manual plunging into liquid ethane (GATAN CRYOPLUNGE 3)
|
Resolution 9.54 Å |
| 3J2J Empty coxsackievirus A9 capsid Deposited 2012-10-04 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 4 Protein homooligomer Homooligomer;Protein × 18 PDB declaration: octadecameric |
Chain A
631–852(222 aa)
Fragment:UNP residues 631-852
Chain B
331–568(238 aa)
Fragment:UNP residues 331-568
Chain C
79–330(252 aa)
Fragment:UNP residues 79-330
|
Not recorded | No recorded non-water small molecule |
ELECTRON MICROSCOPY
cryo-EM vitrification conditions
manual plunging;Cryogen ETHANE;manual plunging into liquid ethane (GATAN CRYOPLUNGE 3)
|
Resolution 9.54 Å |
| 3J2J Empty coxsackievirus A9 capsid Deposited 2012-10-04 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 5 Protein homooligomer Homooligomer;Protein × 3 PDB declaration: trimeric |
Chain A
631–852(222 aa)
Fragment:UNP residues 631-852
Chain B
331–568(238 aa)
Fragment:UNP residues 331-568
Chain C
79–330(252 aa)
Fragment:UNP residues 79-330
|
Not recorded | No recorded non-water small molecule |
ELECTRON MICROSCOPY
cryo-EM vitrification conditions
manual plunging;Cryogen ETHANE;manual plunging into liquid ethane (GATAN CRYOPLUNGE 3)
|
Resolution 9.54 Å |
| 8AT5 native Coxsackievirus A9 Deposited 2022-08-22 | Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 240 PDB declaration: 240-meric |
Chain A
569–867(299 aa)
Chain B
70–330(261 aa)
Chain C
331–568(238 aa)
Chain D
2–69(68 aa)
|
Not recorded | MYR MYRISTIC ACID × 60 PLM PALMITIC ACID × 60 |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.25;PBS containing 2mM MgCl2, pH 7.2
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.90 Å |
| 8AW6 Expanded Coxsackievirus A9 after 0.01% faf-BSA treatment Deposited 2022-08-29 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 180 PDB declaration: 180-meric |
Chain A
569–867(299 aa)
Chain B
70–330(261 aa)
Chain C
331–568(238 aa)
|
Not recorded | No recorded non-water small molecule |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.25;DPBS containing 0.01% faf-BSA, pH 7.25, incubated at 37 C for 1 h
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.50 Å |
| 8AXX Expanded Coxsackievirus A9 after treatment with endosomal ionic buffer Deposited 2022-09-01 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 180 PDB declaration: 180-meric |
Chain A
569–867(299 aa)
Chain B
70–330(261 aa)
Chain C
331–568(238 aa)
|
Not recorded | No recorded non-water small molecule |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.25;endosomal ionic composition buffer, pH 7.25, incubated at 37 C for 3 h
20 mM NaCl, 6 mM KH2PO4, 12 mM K2HPO4, 0.5 mM MgCl2, 0.45 mM CaCl2
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.30 Å |
| 8S7J Coxsackievirus A9 bound with compound 20 (CL300) Deposited 2024-03-01 | Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 240 PDB declaration: 240-meric |
Chain A
569–867(299 aa)
Chain B
70–330(261 aa)
Chain C
331–568(238 aa)
Chain D
2–69(68 aa)
|
Not recorded | A1H9Q ~{N}-[(4-methoxyphenyl)methyl]-4-[(4-methylpiperazin-1-yl)methyl]aniline × 60 MYR MYRISTIC ACID × 60 |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.2;PBS containing 2 mM MgCl2 and 5% DMSO.
cryo-EM vitrification conditions
Cryogen ETHANE;Sample was incubated for 15 s on the grid before blotted from the front for 1.5 s.
|
Resolution 2.26 Å |
| 9EXI Coxsackievirus A9 bound with compound 14 (CL275) Deposited 2024-04-08 | Different construct Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 240 PDB declaration: 240-meric |
Chain A
569–851(283 aa)
Chain B
79–329(251 aa)
Chain C
331–568(238 aa)
Chain D
2–69(68 aa)
|
Not recorded | A1H8J 4-[(4-methylpiperazin-1-yl)methyl]-N-[[4-(trifluoromethyl)phenyl]methyl]aniline × 60 MYR MYRISTIC ACID × 60 |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.2;PBS containing 2 mM MgCl2 and 5% DMSO.
cryo-EM vitrification conditions
Cryogen ETHANE;Sample was incubated for 15 s on the grid before blotted from the front for 1.5 s.
|
Resolution 2.31 Å |
| 9FA9 Coxsackievirus A9 bound with compound 16 (CL298) Deposited 2024-05-10 | Different construct Different ligand/ion Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 240 PDB declaration: 240-meric |
Chain A
569–851(283 aa)
Chain B
70–330(261 aa)
Chain C
331–568(238 aa)
Chain D
2–69(68 aa)
|
Not recorded | A1IBS ~{N}-[(2-fluorophenyl)methyl]-4-[(4-methylpiperazin-1-yl)methyl]aniline × 60 |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.2
cryo-EM vitrification conditions
Cryogen ETHANE;Sample was incubated for 15 s on the grid before blotted from the front for 1.5 s.
|
Resolution 2.75 Å |
| 9FCZ Coxsackievirus A9 bound with compound 17 (CL301) Deposited 2024-05-16 | Different construct Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 240 PDB declaration: 240-meric |
Chain A
569–851(283 aa)
Chain B
79–329(251 aa)
Chain C
331–568(238 aa)
Chain D
2–69(68 aa)
|
Not recorded | A1IB2 ~{N}-[(3-fluorophenyl)methyl]-4-[(4-methylpiperazin-1-yl)methyl]aniline × 60 MYR MYRISTIC ACID × 60 |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.2;PBS containing 2 mM MgCl2 and 5% DMSO.
cryo-EM vitrification conditions
Cryogen ETHANE;Sample was incubated for 15 s on the grid before blotted from the front for 1.5 s.
|
Resolution 2.53 Å |
| 9FGN Coxsackievirus A9 bound with compound 18 (CL304) Deposited 2024-05-24 | Different construct Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 240 PDB declaration: 240-meric |
Chain A
569–850(282 aa)
Chain B
79–328(250 aa)
Chain C
332–567(236 aa)
Chain D
2–68(67 aa)
|
Not recorded | A1ICH ~{N}-[[2,4-bis(fluoranyl)phenyl]methyl]-4-[(4-methylpiperazin-1-yl)methyl]aniline × 60 |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.2;PBS containing 2 mM MgCl2 and 5% DMSO.
cryo-EM vitrification conditions
Cryogen ETHANE;Sample was incubated for 15 s on the grid before blotted from the front for 1.5 s.
|
Resolution 2.64 Å |
| 9FO2 Coxsackievirus A9 bound with compound 15 (CL278) Deposited 2024-06-11 | Different construct Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 240 PDB declaration: 240-meric |
Chain A
569–867(299 aa)
Chain B
79–329(251 aa)
Chain C
331–568(238 aa)
Chain D
2–69(68 aa)
|
Not recorded | A1IEI ~{N}-[(4-fluorophenyl)methyl]-4-[(4-methylpiperazin-1-yl)methyl]aniline × 60 MYR MYRISTIC ACID × 60 |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.2
cryo-EM vitrification conditions
Cryogen ETHANE;Sample was blotted from the front for 1.5 s.
|
Resolution 2.58 Å |
| 9FO5 Coxsackievirus A9 bound with compound 19 (CL313) Deposited 2024-06-11 | Different ligand/ion Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 240 PDB declaration: 240-meric |
Chain A
569–867(299 aa)
Chain B
70–330(261 aa)
Chain C
331–568(238 aa)
Chain D
2–69(68 aa)
|
Not recorded | A1IEH ~{N}-[[3,4-bis(fluoranyl)phenyl]methyl]-4-[(4-methylpiperazin-1-yl)methyl]aniline × 60 |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.2
cryo-EM vitrification conditions
Cryogen ETHANE;Sample was incubated for 15 s on the grid before blotted from the front for 1.5 s.
|
Resolution 2.69 Å |
12 other PDB entries and 21 assemblies. Open the comparison page and filter oligomeric states
View Construct and Data Evidence
| UniProt name | POLG_CXA9 |
| Isoform | — |
| PDB entities | 1, 2, 3, 4 |
| Chains and sequence ranges | Author chain A; PDBConstruct 1–299; UniProt 569–867 Author chain B; PDBConstruct 1–261; UniProt 70–330 Author chain C; PDBConstruct 1–238; UniProt 331–568 Author chain D; PDBConstruct 1–68; UniProt 2–69 |